MAPT and Alzheimer disease: Moreover, 60% of modules showed positive or negative correlation with disease and substantial correlation with AD neuropathological hallmarks, including amyloid deposition in the cerebrovasculature (e.g. CAA) or plaque in the brain parenchyma (CERAD), and tau staging (Braak) (Figure 2A).